In addition, we also aim to analyze the correlation between CREPT and the development of T-cell lymphoma, determine the relationship between high expression of CREPT and T-cell lymphoma, and provide a theoretical basis for CREPT as a potential drug target for the treatment of T-cell lymphoma. The gene discussed is RPRD1B; the disease is T-cell non-Hodgkin lymphoma.